Xuchang KETOP Testing Research Institute Co.,Ltd (003008.SZ)
Xuchang, CN
Headquartered in Xuchang, China, Xuchang KETOP Testing Research Institute Co.,Ltd. has operated as an independent verification provider since its establishment in 2005. The company specializes in offering unbiased assessment and certification for critical components, including secondary protection apparatus for power systems, intelligent micro-grid solutions, and infrastructure for electric vehicle charging and battery exchange.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.74% | -8.31% | -13.43% | -18.81% | -13.62% | -7.89% | -3.03% | -7.97% | -23.65% | -41.08% | -41.08% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Specialty Business Services: +7.6%+5.2% Q1'26: -19.7% (vs Q1'25)
-
EPS growth Specialty Business Services: +24.4%+3.7% Q1'26: -58.1% (vs Q1'25)
-
FCF margin FCF growth · Specialty Business Services: +27.6%+44.1% Q1'26: +12.4% (vs Q1'25)
-
EBIT margin Specialty Business Services: +9.0%+44.5% ★ Q1'26: +18.4% (vs Q1'25)
-
ROIC Specialty Business Services: +7.8%+23.3% ★ Q1'26: +5.8% (vs Q1'25)
-
Share dilution Specialty Business Services: +0.4%-0.6% ★ Q1'26: +2.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Specialty Business Services: -0.21×0.00× ★ Q1'26: 0.01× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
232.73M
est: 259.00M (-10.1%)
|
284.00M
284.00M – 284.00M
+9.7% YoY
|
345.00M
345.00M – 345.00M
+21.5% YoY
|
426.00M
426.00M – 426.00M
+23.5% YoY
|
| EBITDA |
158.17M
est: 188.03M (-15.9%)
|
206.18M
206.18M – 206.18M
+9.7% YoY
|
250.47M
250.47M – 250.47M
+21.5% YoY
|
309.27M
309.27M – 309.27M
+23.5% YoY
|
| EBIT |
103.56M
est: 124.27M (-16.7%)
|
136.27M
136.27M – 136.27M
+9.7% YoY
|
165.54M
165.54M – 165.54M
+21.5% YoY
|
204.40M
204.40M – 204.40M
+23.5% YoY
|
| Net Income |
88.19M
est: 100.64M (-12.4%)
|
113.10M
113.10M – 113.10M
+12.4% YoY
|
139.03M
139.03M – 139.03M
+22.9% YoY
|
168.09M
168.09M – 168.09M
+20.9% YoY
|
| SGA |
15.72M
est: 46.72M (-66.4%)
|
51.23M
51.23M – 51.23M
+9.7% YoY
|
62.24M
62.24M – 62.24M
+21.5% YoY
|
76.85M
76.85M – 76.85M
+23.5% YoY
|
| EPS |
0.85
est: 0.97 (-12.4%)
|
1.09
1.09 – 1.09
+12.4% YoY
|
1.34
1.34 – 1.34
+22.9% YoY
|
1.62
1.62 – 1.62
+20.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 4/5 | 2/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chun He | Department Director, Vice President & Deputy GM | — | male |
| Guodong Li | Chief Financial Officer & Accounting Supervisor | — | male |
| Ran Zhang | Deputy GM & Board Secretary | — | male |
| Wei Wang | Department Director, Vice President & Deputy GM | — | male |
| Xia Song | Department Director, Vice President & Deputy GM | — | female |
| Yaping Li | President, GM & Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 003008.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
